Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: A multicenter study

Cancer

Volumn 88, Issue 5, 2000, Pages 1099-1107

  Weaver, Donald L ^a,b   Krag, David N ^a   Ashikaga, Takamaru ^a   Harlow, Seth P ^a   O'Connell, Maureen ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Breast carcinoma; Immunohistochemistry; Occult metastases; Sentinel lymph node

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL;

AXILLA; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 0034161649     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.0.CO;2-7     Document Type: Article

References (60)

1. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. Breast. American Joint Committee on Cancer cancer staging manual. 5th edition. New York: Lippincott-Raven, 1997:171-80.
2. Assa J. The intercostobrachial nerve in radical mastectomy. J Surg Oncol 1974;6:123-6.
3. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot to provide parameter estimates. J Surg Oncol 1992;50:47-52.
4. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-82.
5. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
6. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
7. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
8. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
9. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-6.
10. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
11. Cabanas RM. An approach for the treatment of penile cancer. Cancer 1977;39:456-66.
12. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137-43.
13. Terui S, Kato H, Hirashima T, Lizuka T, Oyamada H. An evaluation of the mediastinal lymphoscintigram for carcinoma of the esophagus studied with 99mTc rhenium sulfur colloid. Eur J Nucl Med 1982;7:99-101.
14. Weinberg J, Greaney EM. Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer. Surg Gynecol Obstet 1950;90:561-7.
15. Weinberg JA. Identification of regional lymph nodes in the treatment of bronchiogenic carcinoma. J Thorac Surg 1951; 22:517-26.
16. Apostolikas N, Petraki C, Agnantis AG. The reliability of histologically negative axillary lymph nodes in breast cancer. Pathol Res Pract 1988;184:35-8.
17. Attiyeh FF, Jensen M, Huvos AG, Fracchia A. Axillary micrometastases and macrometastases in carcinoma of the breast. Surg Gynecol Obset 1977;144(6):839-42.
18. Berry N, Jones D, Marshall R, Smallwood J, Taylor I. Comparison of the detection of breast carcinoma metastases by routine histological diagnosis and by immunohistochemical staining. Eur Surg Res 1988;20(4):225-32.
19. Black RB, Roberts M, Stewart HJ, Prescott R, Cant EL, Sumerling MD, et al. The search for occult metastases in breast cancer: does it add to established staging methods? Aust N Z J Surg 1980;50(6):574-9.
20. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1986;54(4):631-6.
21. Byrne J, Morgan P, England SS, Callaghan J, Given HF. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast cancer. Eur J Surg 1992;28:658-60.
22. Byrne J, Waldron R, McAvinchey D, Dervan P. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. Eur J Surg Oncol 1987;13(5):409-11.
23. Chen Z-L, Wen D-L, Coulson WF, Giuliano AE, Cochran AJ. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histological examination and conventional histology. Dis Markers 1991; 9(5):239-48.
24. Clayton F, Hopkins CL. Pathologic correlates of prognosis in lymph node positive breast carcinomas. Cancer 1993;71(5): 1780-90.
25. de Mascarel I, Binichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary node micrometastases assessed by two special techniques: re-evaluation with longer follow-up. Br J Cancer 1992;66(3):523-7.
26. Elson CE, Kulfe D, Johnson WW. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. Anal Quant Cytol Histol 1993; 15(3):171-8.
27. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;42:2025-31.
28. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, et al. Importance of tumor cells in axillary node sinus margins (clandestine metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol 1988;27(5): 483-7.
29. Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, et al. Occult regional lymph node metastases from breast carcinoma. Immunohistochemical detection with antibodies CAM 5.2 and NCRC-11. J Pathol 1991;165(3): 221-7.
30. Hainsworth PJ, Tjandra J, Stillwell RG, Machet D, Henderson MA, Rennie GC, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 1993; 80(4):459-63.
31. Huvos AG, Hutter R, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173(1):44-6.
32. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990;335(8749):1565-8.
33. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73(1):88-95.
34. Nasser IA, Lee A, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24(9):950-7.
35. Neville AM, Price K, Gelber RD, Goldhirsch A. Axillary node micrometastases and breast cancer. Lancet 1991;337(8749): 1110.
36. Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer 1961;14:1266-71.
37. Raymond WA, Leong A-Y. Immunoperoxidase staining in the detection of lymph node metastases in Stage I breast cancer. Pathology 1989;21:11-5.
38. Rosen PP, Saigo P, Weathers E, Fracchia AA, Kinne DW. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg 1981;194(5):585-91.
39. Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948;1:238-41.
40. Sedmak DD, Meineke T, Knechtges DS. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med 1989;113:786-9.
41. Sloane JP, Ormerod M, Imrie SF, Coonbes RC. The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer 1980;42(3): 392-8.
42. Springall RJ, Rytina E, Millis RR. Incidence and significance of micrometastases in axillary lymph nodes detected by immunohistochemical techniques. J Pathol 1990;160:174A.
43. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of the breast. Br J Cancer 1987;55(3):303-6.
44. Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY. The immunohistochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50(2):193-7.
45. Wilkinson EJ, Hause L, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 1982; 17(Pt 2):67-91.
46. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
47. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
48. Dixon WJ, Massey FJ. Nonparametric statistics. Introduction to statistical analysis. New York: McGraw-Hill, 1969:349-51.
49. Fleiss FJ. Sampling method I: naturalistic or cross-sectional studies. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1973:43-6.
50. StatXact3 for Windows [software]. Cambridge, MA: Cytel Software Corporation, 1995.
51. SAS Technical Report P-229 (Release 6.07) [software}. Cary, NC: SAS Institute Inc., 1992.
52. Gray JH. The relation of lymphatic vessels to the spread of cancer. Br J Surg 1938;26:462-95.
53. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97.
54. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-9.
55. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227: 645-53.
56. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998;4:67-74.
57. Krag DN, Harlow SP, Weaver DL, Ashikaga T. Technique of selected resection of radiolabeled lymph nodes in breast cancer patients. Semin Breast Dis 1998;1:111-6.
58. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85.
59. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
60. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-81.